World Bulletin / News Desk
Open access worldwide to the new database, based on genome studies, is expected to help researchers accelerate development of new drugs and better match patients with therapies, NCI said in a statement on Monday.
"Most anti-cancer drugs that are used today are used based on their empirical activity," Dr. Yves Pommier, chief of the NCI's Laboratory of Molecular Pharmacology, said in an interview. "For most of them, we know there is a target, but they have not been connected with any genomics."
Most cancer treatments involve a lot of guess work because doctors have no way to determine how a particular patient is likely to respond to many commonly used drugs or chemotherapy, or which cancers will develop resistance.
To create the database, the NCI team sequenced 60 human cancer cell lines, generating an extensive list of cancer-specific variations for different parts of the body.
"Only about half of women with ovarian cancer respond to it," he said, noting that pharmaceutical companies would have little incentive to determine if an existing cancer drug should only be used in a subset of patients.
Many recently approved cancer drugs are targeted treatments, designed to block specific pathways that cancer cells use to grow and reproduce. Before the drugs are administered, patients are tested for the specific genetic mutations that would make the drug more likely to be beneficial to them.
Melanoma drug Zelboraf, sold by Roche Holding AG, is designed to work by targeting a specific genetic mutation found in about half of all melanomas. Pfizer Inc's cancer drug Xalkori, which targets a mutation in the ALK gene, works in about 4 percent of lung cancer patients.
A man left brain-dead after an experimental drug trial in France has died, local media report.
Facebook founder to donate majority of fortune over lifetime to newly formed charity
Facebook will appeal a date privacy ruling in Belgium that forces the social media giant to stop collecting digital information about people who are non-members
Japanese, Chinese, Irish scientists win 2015 Nobel prize in medicine for malaria and parasite research
Discovery could have major implications for pursuit of life on the red planet
Lawsuit sheds light on no poaching policy at Silicon Valley’s biggest companies
Searches for oncoming storms will display information such as maps, forecasts, reminders and preparedness instructions
New service unveiled as survey finds Americans having hard time navigating smartphone etiquette
Turkcell, Vodafone and Avea bid total of over €1.14 billion for the right to use frequencies on the new network
Petition 'will present at least two substantial questions concerning design-patent liability and damages'
The Istanbul Electric Tram and Tunnel Company plans to launch one solar-powered bus on Thursday and several more in the coming days
Roughly 70 million tonnes of fibres are traded globally per year, but nearly two thirds are made from non-renewable products like petroleum and natural gas.
Researchers havfe said that the flaw leaves data stored by apps vulnerable with almost every category of app considered vulnerable
SpaceX revealed Monday that it is building a test track for the Hyperloop, a concept for ultra-fast ground transport the company’s CEO, Elon Musk, unveiled.
Biologists have created chicken embryos with dinosaur-like faces by tinkering with the molecules that build the birds' beaks.
Product available for pre-order in nine countries but devices won’t ship for weeks.